Valence ロゴ
人気
ログイン
Loading data for LEGN — first visit, this takes a few seconds.

ウォッチリストに追加

Legend Biotech Corporatio...

NasdaqGS: LEGN · リアルタイム株価 · USD
19.88
-0.62 (-3.02%)
終値時点： Aug 28, 2026, 8:00 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Legend Biotech Corporation（LEGN）の株価・分析・データ

-3.02%

データがありません

買気配14.68
時価総額3.87B
売上高（TTM）1.27B
純利益（TTM）-91.5M
0.39
-0.5
n/a
18.41
PBR（TTM）3.13
PSR（TTM）3.04
決算発表日Nov 11, 2026
売気配19.92
出来高1,151,162
平均出来高（20日）2,731,144
始値20.42
前日終値20.50
当日レンジ19.85 - 20.59
52週レンジ16.24 - 37.50
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

LEGNについて

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 Jun 5, 2020
従業員数 3,200
上場取引所 NasdaqGS
ティッカー LEGN
ウェブサイト https://legendbiotech.com
企業情報の全文

業績

2025年のLegend Biotechの売上高は1.03Bで、前年の627.3Mから64.02%の増加でした。 利益は-296.8Mで、67.68%の増加でした。

財務諸表

決算サプライズ

Legend BiotechはAug 11, 2026に四半期決算を発表しました：
  • 売上高は $305.1M で、予想を下回りました $0, うち 56.46% の前年比増加にあたります.
  • EPSは 0.32 で、予想を上回りました 0.04, うち 159.26% の前年比増加にあたります.

次回決算発表

Legend Biotech Corporationの決算発表予定日は Nov 11, 2026, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード
news image

2週間前 · MT Newswires

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t

news image

2週間前 · 24/7 Wall St.

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More

With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall Street analysts are already repositioning across hospitality, pharma, and tech before the market even...

news image

2週間前 · Motley Fool

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript

CARVYKTI sales surged 50% globally as company swung to profitability.

news image

2週間前 · GuruFocus.com

Legend Biotech Corp (LEGN) (Q2 2026) Earnings Call Highlights: First Profitable Quarter Driven ...

Legend Biotech achieves company-wide profitability with adjusted net income of $63 million, while advancing its promising in vivo CAR-T platform.

news image

2週間前 · 24/7 Wall St.

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech just posted a quarter that flipped a key narrative for LEGN shareholders, but with a CEO transition underway and the stock still down sharply over the past year, the real question is wh...

2ページ中1ページ